Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: The Clinical Relevance of Micro RNAs in Mild Traumatic Brain Injury

View source ↗

Summary

This clinical trial update discusses the investigation of microRNAs as clinically relevant biomarkers in mild traumatic brain injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Harald Wolf, MD | Conditions: Brain Injuries, Traumatic | Status: COMPLETED